Why physicians join our infectious disease community
Sermo’s infectious disease physician network provides practicing infectious disease physicians with a secure, peer-driven platform to discuss emerging pathogens, antimicrobial stewardship, infection prevention, and global health threats. Whether you focus on hospital-based consults, outpatient ID care, HIV medicine, transplant infections, or public health, Sermo connects you to peers facing similar challenges—from managing drug-resistant organisms and evolving treatment guidelines to navigating outbreaks and complex immunocompromised patients.
Connect with leading infectious disease experts
Tap into one of the largest online communities of practicing infectious disease physicians across general infectious disease, HIV, transplant infectious disease, hospital epidemiology, and global health.
Add to real-time clinical discussions
Engage in peer-driven conversations on complex infections, diagnostic uncertainty, antimicrobial selection, and infection control challenges.
Influence long-term infection management
Join discussions on managing chronic infectious conditions like HIV, hepatitis, and latent TB, coordinating multidisciplinary care and guiding patients through long-term treatment and monitoring.
Keep up with emerging infectious disease insights
Discover the latest conversations and breakthroughs in novel antimicrobials, vaccines, antiviral therapies, and diagnostic technologies—keeping you at the forefront of your field.
Make confident treatment decisions
Access peer-reviewed drug ratings to support informed treatment decisions, grounded in real-world physician experience.
Collaborate on patient care solutions
Exchange frontline experiences, stewardship strategies, and clinical protocols with peers in a secure, physician-only community.
Earn money sharing your infectious disease expertise
Learn why surveys are worth it for infectious disease physicians and tackle topics such as:
- Surveys on antimicrobial stewardship programs
- Opinion polls on empiric vs targeted therapy approaches
- Research studies on emerging infections and resistance patterns
Access infectious disease drug insights from peers
Get practical, peer-reviewed information on anti-infective treatments:
- Detailed safety profiles of antibiotics, antivirals, antifungals, and vaccines
- Comparative efficacy assessments
- Real-world tolerability experiences
- FDA approval timelines for new anti-infective agents and practical use cases
Learn from infectious disease articles and case studies
Discover strategies and real-world advice based on insights from physicians on Sermo.
- Managing multidrug-resistant infections
- Communicating serious diagnoses like HIV or invasive fungal disease
- Barriers to adherence with long-term antimicrobial therapy
- Responding to emerging outbreaks and public health threats
Hear from fellow physician peers
My favorite part of Sermo is publishing real clinical cases that have happened to me and being able to hear the opinions of other colleagues. This helps me grow professionally and broaden my knowledge. At the same time, I like to respond to colleagues’ clinical cases to give them my support.
It helps a lot to solve clinical cases. I love participating in the comments as well as in the promotions. Of course I always recommend Sermo to my colleagues. Excellent platform
My favorite part of Sermo is the wide variety of clinical cases that we can explore and learn from, as well as the opportunity to be part of a social network exclusively for healthcare professionals. It’s a pleasure to contribute to this community.
Frequently asked questions
Sermo’s infectious disease community regularly shares updates and discussions around FDA approvals, trial outcomes, and real-world experiences with new antimicrobials, antivirals, vaccines, and diagnostics.
Yes. Our drug ratings feature allows infectious disease physicians to review and compare treatments across efficacy, safety, and tolerability—based on real-world experiences.
Absolutely. Sermo members frequently share information related to clinical trial eligibility for HIV, hepatitis, emerging infections, and novel antimicrobial agents, as well as recruitment challenges.
Yes. Whether you focus on inpatient consults, outpatient ID clinics, HIV care, or public health, Sermo provides a space to share your expertise and learn from others.
You’ll find case studies ranging from diagnostic dilemmas and culture interpretation to outbreak response, infection prevention strategies, and management of complex immunocompromised patients.
Yes. Many discussions focus on stewardship metrics, reimbursement for ID services, infection prevention policies, and institutional protocols.
Sermo enables real-time collaboration. Post a case anonymously and receive input within hours—helping you make confident decisions when time and clarity matter most.
Sermo is designed to complement—not replace—professional societies and formal networks. It gives physicians a place for real-time peer discussion, specialty-specific insights, and opportunities to contribute to paid research, all within a physician-only community that fits easily into day-to-day practice.
If you’d like to see how Sermo compares with other physician networks, explore how we differ from Doximity or M3 Global.
Start your infectious disease journey on Sermo
Become part of a dynamic infectious disease physician network of over 15,000 members dedicated to advancing patient care and public health through peer collaboration and expert insights.
